Skip to main content
OpenTrials

Clinical trial condition

Acquired Bleeding Disorder

Explore clinical trials studying Acquired Bleeding Disorder. Study availability and eligibility vary by location and protocol.

22 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Acquired Bleeding Disorder trial results

Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Severely Injured Trauma Patients

NCT01563523

Conditions
Acquired Bleeding Disorder, Trauma, Wounds and Injuries
Locations
  • Novo Nordisk Investigational Site Perth, Australia
  • Novo Nordisk Investigational Site Graz, Austria
  • Novo Nordisk Investigational Site Toronto, Ontario, Canada
  • Novo Nordisk Investigational Site Paris, France
View Trial Details
Completed

Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

NCT00123591

Conditions
Acquired Bleeding Disorder, Trauma, Wounds and Injuries
Locations
  • Novo Nordisk Investigational Site Montreal, Canada
  • Novo Nordisk Investigational Site Helsinki, Finland
  • Novo Nordisk Investigational Site Hanover, Germany
  • Novo Nordisk Investigational Site New Dehli, New Delhi, India
View all 15 locations
View Trial Details
Completed

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

NCT00127283

Conditions
Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
Locations
  • Novo Nordisk Investigational Site Birmingham, Alabama, United States
  • Novo Nordisk Investigational Site Mobile, Alabama, United States
  • Novo Nordisk Investigational Site Phoenix, Arizona, United States
  • Novo Nordisk Investigational Site Fort Smith, Arkansas, United States
View all 167 locations
View Trial Details
Completed

Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage

NCT01566786

Conditions
Acquired Bleeding Disorder, Brain Diseases, Cardiovascular Diseases, +10 more
Locations
  • Novo Nordisk Investigational Site Parkville, Victoria, Australia
  • Novo Nordisk Investigational Site Copenhagen, Denmark
  • Novo Nordisk Investigational Site Jyväskylä, Finland
  • Novo Nordisk Investigational Site Heidelberg, Germany
View Trial Details
Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

NCT01562158

Conditions
Acquired Bleeding Disorder, Bleeding During/Following Surgery
Locations
  • Novo Nordisk Investigational Site Chapel Hill, North Carolina, United States
  • Novo Nordisk Investigational Site Herston, Australia
  • Novo Nordisk Investigational Site Parkville, Australia
  • Novo Nordisk Investigational Site Westmead, Australia
View all 46 locations
View Trial Details
Completed

Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

NCT01601613

Conditions
Acquired Bleeding Disorder, Arbovirus Infections, Dengue, +9 more
Locations
  • Novo Nordisk Investigational Site Kuala Lumpur, Malaysia
  • Novo Nordisk Investigational Site City of Muntinlupa, Philippines
  • Novo Nordisk Investigational Site Manila, Philippines
  • Novo Nordisk Investigational Site Quezon City, Philippines
View Trial Details
Completed

Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass

NCT02239146

Conditions
Acquired Bleeding Disorder, Cardiac Surgery Requiring Cardiopulmonary Bypass
Locations
  • Novo Nordisk Investigational Site Tucson, Arizona, United States
  • Novo Nordisk Investigational Site San Francisco, California, United States
  • Novo Nordisk Investigational Site Denver, Colorado, United States
  • Novo Nordisk Investigational Site Indianapolis, Indiana, United States
View all 24 locations
View Trial Details

Related conditions